News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1โ€“11
Matches
11
Sources here
4
Companies here
1
Search results Stored financial headlines

Active search

11 matching headlines

Ticker or company: ZURAMain companies and provider mentions
Clear

ZURA (ZURA) insider Someit Sidhu plans 40,000-share sale after option exercise

Someit Sidhu, an insider at Zura Bio Ltd (ZURA), plans to sell 40,000 shares of common stock for an aggregate value of $220,540.00 on or after August 14, 2026, on NASDAQ, following a stock option exercise on August 13, 2026. This filing also discloses โ€ฆ

ZURA main company
Sharemaestro market context Price above Trend Line 52 weeks +186.8% ZURA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Zura Bio (NASDAQ: ZURA) director plans 50,000-share sale after prior trades

A director of Zura Bio (NASDAQ: ZURA), Someit Sidhu, intends to sell 50,000 common shares valued at $287,712.50, originating from a stock option exercise, on August 18, 2026. This planned sale follows several prior sales of ZURA common stock by the same individual within โ€ฆ

ZURA main company
Sharemaestro market context Price above Trend Line 52 weeks +186.8% ZURA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Zura Bio (NASDAQ: ZURA) affiliate plans stock sale via option exercise

An affiliate of Zura Bio (NASDAQ: ZURA), Someit Sidhu, has filed a Form 144 indicating a planned sale of 27,000 shares of ZURA common stock on or about August 17, 2026. This sale will be executed for cash through Morgan Stanley Smith Barney LLC โ€ฆ

ZURA main company
Sharemaestro market context Price above Trend Line 52 weeks +186.8% ZURA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Zura Bio Ltd SEC Filing (Aug 13, 2026)

This article reports on an SEC Form 144 filing by Zura Bio Ltd on August 13, 2026. The filing indicates a proposed sale of 51,000 shares of common stock, acquired through a stock option exercise, with an aggregate market value of $287,043.30, to be โ€ฆ

ZURA main company
Sharemaestro market context Price above Trend Line 52 weeks +186.8% ZURA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Zura Bio Completes Enrollment in 247-Participant Hidradenitis Study

Zura Bio announced the completion of enrollment for its Phase 2 TibuSHIELD study in hidradenitis suppurativa (HS) with 247 participants and the TibuSURE study in systemic sclerosis (SSc) with 91 participants, both exceeding initial targets. The company also reported its Q2 2026 financial results, โ€ฆ

ZURA main company
Sharemaestro market context Price above Trend Line 52 weeks +186.8% ZURA stored weekly price path from 29 Aug 2025 to 21 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context